Correlation Between CRISPR Therapeutics and Anglesey Mining

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both CRISPR Therapeutics and Anglesey Mining at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining CRISPR Therapeutics and Anglesey Mining into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between CRISPR Therapeutics AG and Anglesey Mining plc, you can compare the effects of market volatilities on CRISPR Therapeutics and Anglesey Mining and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in CRISPR Therapeutics with a short position of Anglesey Mining. Check out your portfolio center. Please also check ongoing floating volatility patterns of CRISPR Therapeutics and Anglesey Mining.

Diversification Opportunities for CRISPR Therapeutics and Anglesey Mining

-0.22
  Correlation Coefficient

Very good diversification

The 3 months correlation between CRISPR and Anglesey is -0.22. Overlapping area represents the amount of risk that can be diversified away by holding CRISPR Therapeutics AG and Anglesey Mining plc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Anglesey Mining plc and CRISPR Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on CRISPR Therapeutics AG are associated (or correlated) with Anglesey Mining. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Anglesey Mining plc has no effect on the direction of CRISPR Therapeutics i.e., CRISPR Therapeutics and Anglesey Mining go up and down completely randomly.

Pair Corralation between CRISPR Therapeutics and Anglesey Mining

Assuming the 90 days trading horizon CRISPR Therapeutics is expected to generate 23.76 times less return on investment than Anglesey Mining. But when comparing it to its historical volatility, CRISPR Therapeutics AG is 27.93 times less risky than Anglesey Mining. It trades about 0.13 of its potential returns per unit of risk. Anglesey Mining plc is currently generating about 0.11 of returns per unit of risk over similar time horizon. If you would invest  0.30  in Anglesey Mining plc on April 21, 2025 and sell it today you would lose (0.25) from holding Anglesey Mining plc or give up 83.33% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

CRISPR Therapeutics AG  vs.  Anglesey Mining plc

 Performance 
       Timeline  
CRISPR Therapeutics 

Risk-Adjusted Performance

OK

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in CRISPR Therapeutics AG are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively fragile basic indicators, CRISPR Therapeutics unveiled solid returns over the last few months and may actually be approaching a breakup point.
Anglesey Mining plc 

Risk-Adjusted Performance

OK

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Anglesey Mining plc are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. Despite nearly fragile basic indicators, Anglesey Mining reported solid returns over the last few months and may actually be approaching a breakup point.

CRISPR Therapeutics and Anglesey Mining Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with CRISPR Therapeutics and Anglesey Mining

The main advantage of trading using opposite CRISPR Therapeutics and Anglesey Mining positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if CRISPR Therapeutics position performs unexpectedly, Anglesey Mining can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Anglesey Mining will offset losses from the drop in Anglesey Mining's long position.
The idea behind CRISPR Therapeutics AG and Anglesey Mining plc pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.

Other Complementary Tools

Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Insider Screener
Find insiders across different sectors to evaluate their impact on performance